BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37610851)

  • 1. Design, synthesis and biological evaluation of novel oxindole analogs as antitubercular agents.
    Khetmalis YM; Sangeetha GP; Chandu A; Swati ; Murugesan S; Sharma V; Kumar MM; Kondapalli VG
    Future Med Chem; 2023 Aug; 15(15):1323-1342. PubMed ID: 37610851
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against
    Nandikolla A; Khetmalis YM; Venkata Siva Kumar B; Chandu A; Karan Kumar B; Shetye G; Ma R; Murugesan S; Franzblau SG; Chandra Sekhar KVG
    RSC Med Chem; 2023 Aug; 14(8):1549-1561. PubMed ID: 37593576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2-
    Khetmalis YM; Chitti S; Umarani Wunnava A; Karan Kumar B; Murali Krishna Kumar M; Murugesan S; Chandra Sekhar KVG
    RSC Med Chem; 2022 Mar; 13(3):327-342. PubMed ID: 35434623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
    Patil PS; Kasare SL; Haval NB; Khedkar VM; Dixit PP; Rekha EM; Sriram D; Haval KP
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127434. PubMed ID: 32717369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents.
    Nandurkar Y; Bhoye MR; Maliwal D; Pissurlenkar RRS; Chavan A; Katade S; Mhaske PC
    Eur J Med Chem; 2023 Oct; 258():115548. PubMed ID: 37307623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitutedpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues.
    Nandikolla A; Mahadu Khetmalis Y; Mahalakshmi Naidu K; Karan Kumar B; Murugesan S; Chandra Sekhar KVG
    Toxicol In Vitro; 2022 Aug; 82():105370. PubMed ID: 35489549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.
    Mekonnen Sanka B; Mamo Tadesse D; Teju Bedada E; Mengesha ET; Babu G N
    Bioorg Chem; 2022 Feb; 119():105568. PubMed ID: 34968884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
    Nayak N; Ramprasad J; Dalimba U
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bakale RD; Phatak PS; Rathod SS; Choudhari PB; Rekha EM; Sriram D; Kulkarni RS; Haval KP
    J Biomol Struct Dyn; 2023 Dec; ():1-20. PubMed ID: 38079301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
    Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
    Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and molecular docking studies of novel quinazolinones as antitubercular and antimicrobial agents.
    Kumar Pandey S; Yadava U; Upadhyay A; Sharma ML
    Bioorg Chem; 2021 Mar; 108():104611. PubMed ID: 33484939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethionamide and Prothionamide Based Coumarinyl-Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies.
    Imran M
    Pharm Chem J; 2022; 56(9):1215-1225. PubMed ID: 36531826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
    Desai NC; Trivedi AR; Somani HC; Bhatt KA
    Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
    Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents.
    Reddy DS; Sinha A; Kurjogi MM; Shanavaz H; Kumar A
    Arch Pharm (Weinheim); 2023 May; 356(5):e2200633. PubMed ID: 36634969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.